| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | Nordea Bank Abp: The Nomination Board's proposals to Nordea's Annual General Meeting 2026 include a new Board member | ||
| Do | Hunter Group ASA: Shareholding disclosure | ||
| Do | Pexip Holding ASA: Dial-in details to Pexip's Q4 2025 results on February 12 | ||
| Do | EXACT Therapeutics AS: EXACT Therapeutics: Correction of final warrants exercise date | ||
| Do | Reminder: SpareBank 1 Nord-Norge is presenting Preliminary Annual Accounts 2025 | ||
| Do | Norsk Titanium AS - Share capital increase registered | ||
| Do | Aker ASA: Invitation to Presentation of Fourth Quarter Results 2025 | ||
| Do | Eidesvik Offshore ASA: EIOF - Changes to the Board of Directors | ||
| Do | Endúr ASA - Contract award BMO | ||
| Do | Avinor AS: Passengers at Avinor airports week 5 2026 | ||
| Do | ArcticZymes Technologies ASA: Invitation to presentation of Q4 and FY 2025 results | ||
| Do | Agilyx ASA - New share capital | ||
| Do | Vistin Pharma ASA: Invitation to Q4 2025 conference call | ||
| Do | Cloudberry Clean Energy ASA | Invitation to presentation of fourth quarter of 2025 | ||
| Do | Reach Subsea ASA - Invitation to presentation of the fourth quarter and preliminary full year results 2025. | ||
| Do | EXACT Therapeutics AS: EXACT Therapeutics: Warrants exercise by leading shareholders and primary insiders | ||
| Do | Euronext Oslo Børs - Sola kommune - Received application for listing of bonds | ||
| Do | EXACT Therapeutics AS: EXACT Therapeutics: Exercise of Warrants by GE Medical Holding AB | ||
| Do | Moreld ASA - Invitation to presentation of Moreld s fourth quarter and full year 2025 results | ||
| Do | Green Minerals AS: Green Minerals: 2H 2025 report and presentation | ||
| Do | Himalaya Shipping Ltd. - Invitation to Fourth Quarter 2025 Conference Call | ||
| Do | Norwegian Air Shuttle ASA - Traffic Figures for January 2026 | ||
| Do | Pyrum Innovations AG: Pyrum and UniPyrum sign engineering contract for first joint venture plant: Start of next project phase at Emleben site | ||
| Do | Lifecare ASA: Lifecare submits updated documentation to NoMA: regulatory review resumes in first-in-human study application | ||
| Do | Nordic Semiconductor ASA: NOD: Share Buyback Program |